SYN - Synthetic Biologics Inc. (SYN) CEO Steven Shallcross on Q2 2021 Results - Earnings Call Transcript

Synthetic Biologics, Inc. (SYN) Q2 2021 Earnings Conference Call August 5, 2021 4:30 PM ET Company Participants Vincent Perrone – Director, Corporate Communication Steven Shallcross - Chief Executive and Financial Officer Michael Kaleko - Senior Vice President-Research and Development Vince Wacher - Head-Product and Corporate Development Conference Call Participants James Molloy - Alliance Global Partners Michael Okunewitch - Maxim Group Presentation Operator Good afternoon, and welcome to Synthetic Biologics’ 2021 Second Quarter Investor Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note, this event is being recorded. At this time, I would like to turn the call over to Mr. Vincent Perrone, Director of Corporate Communication at Synthetic Biologics. Please go ahead, Mr. Perrone. Vincent Perrone Thanks, Alexi, and good afternoon, everyone. Welcome to Synthetic Biologics 2021 second quarter investor conference call. Today, I am joined remotely by Steven Shallcross, Chief Executive and Financial Officer; Dr.

For further details see:

Synthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q2 2021 Results - Earnings Call Transcript